FR2741350B1 - Peptides derives de la proteine oncogene bcr-abl exprimes par des cellules leucemiques et leur utilisation pour la therapie des leucemies humaines - Google Patents

Peptides derives de la proteine oncogene bcr-abl exprimes par des cellules leucemiques et leur utilisation pour la therapie des leucemies humaines

Info

Publication number
FR2741350B1
FR2741350B1 FR9513610A FR9513610A FR2741350B1 FR 2741350 B1 FR2741350 B1 FR 2741350B1 FR 9513610 A FR9513610 A FR 9513610A FR 9513610 A FR9513610 A FR 9513610A FR 2741350 B1 FR2741350 B1 FR 2741350B1
Authority
FR
France
Prior art keywords
leucemic
oncogen
bcr
therapy
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9513610A
Other languages
English (en)
Other versions
FR2741350A1 (fr
Inventor
Demoyen Pierre Langlade
Jean Pierre Abastado
Philippe Kourilsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR9513610A priority Critical patent/FR2741350B1/fr
Priority to PCT/FR1996/001799 priority patent/WO1997018232A2/fr
Publication of FR2741350A1 publication Critical patent/FR2741350A1/fr
Application granted granted Critical
Publication of FR2741350B1 publication Critical patent/FR2741350B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9513610A 1995-11-16 1995-11-16 Peptides derives de la proteine oncogene bcr-abl exprimes par des cellules leucemiques et leur utilisation pour la therapie des leucemies humaines Expired - Fee Related FR2741350B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9513610A FR2741350B1 (fr) 1995-11-16 1995-11-16 Peptides derives de la proteine oncogene bcr-abl exprimes par des cellules leucemiques et leur utilisation pour la therapie des leucemies humaines
PCT/FR1996/001799 WO1997018232A2 (fr) 1995-11-16 1996-11-14 Peptides derives de la proteine oncogene bcr-abl exprimes par des cellules leucemiques et leur utilisation pour la therapie des leucemies humaines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9513610A FR2741350B1 (fr) 1995-11-16 1995-11-16 Peptides derives de la proteine oncogene bcr-abl exprimes par des cellules leucemiques et leur utilisation pour la therapie des leucemies humaines

Publications (2)

Publication Number Publication Date
FR2741350A1 FR2741350A1 (fr) 1997-05-23
FR2741350B1 true FR2741350B1 (fr) 1998-02-06

Family

ID=9484638

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9513610A Expired - Fee Related FR2741350B1 (fr) 1995-11-16 1995-11-16 Peptides derives de la proteine oncogene bcr-abl exprimes par des cellules leucemiques et leur utilisation pour la therapie des leucemies humaines

Country Status (2)

Country Link
FR (1) FR2741350B1 (fr)
WO (1) WO1997018232A2 (fr)

Also Published As

Publication number Publication date
WO1997018232A3 (fr) 1997-07-03
WO1997018232A2 (fr) 1997-05-22
FR2741350A1 (fr) 1997-05-23

Similar Documents

Publication Publication Date Title
GR1002147B (en) Human tissue factor related dna segments poypeptides and antibodies
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
DE69627228D1 (de) Biokompatible medizinische Elektrodenleitung
ITBO960478A0 (it) Procedimento per la stimolazione controllata di regioni predefinite del corpo umano tramite l'applicazione di segnali elettrici variabili
DE69634519D1 (de) Katheter zur ablation von atrio-ventikulären gewebe
BR9708980A (pt) Aperfeiçoamento das taxas de implantação após fertilização invitro
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
EP0821969A3 (fr) Composition médicale contenant du TCF-II
HUP9802834A3 (en) Preparations for the treatment of t cell mediated autoimmune diseases
IT8921128A0 (it) Metodo per la determinazione della attivita' funzionale della proteina s nel plasma umano.
FR2741350B1 (fr) Peptides derives de la proteine oncogene bcr-abl exprimes par des cellules leucemiques et leur utilisation pour la therapie des leucemies humaines
ATE238796T1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
DK0820507T3 (da) NDF-peptider
DE59802065D1 (de) Membransystem zur gesteuerten geweberegeneration bei erkrankungen des zahnhalteapparates
FR2682598B1 (fr) Compositions pharmaceutiques de peptides et procedes pour leur preparation.
FR2750427B1 (fr) Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique
KR940004888U (ko) 양산, 우산용 착탈식 인체세움고정대
IT1282951B1 (it) Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento dell'insonnia
IL117383A0 (en) Pharmaceutical preparations from peptides which boost the immune response treat diseases and balance biological systems
IL112347A0 (en) Medicinal preparation for the treatment of aids
AU2978297A (en) Novel human receptor type tyrosine kinase-like protein
DZ1915A1 (fr) Nouveaux peptides opioïdes pour le traitement de la douleur et leur usage.
IL118776A0 (en) Pharmaceutical cosmetic diagnostic and therapeutic compositions incorporating proteins derived from a MUC1 gene and methods utilizing the same
ATA51896A (de) Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen

Legal Events

Date Code Title Description
ST Notification of lapse